VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,314,727 | +24.7% | 1,565,209 | +28.5% | 0.01% | +20.0% |
| Q1 2023 | $8,268,977 | +244979.3% | 1,217,817 | +166.7% | 0.01% | +100.0% |
| Q4 2022 | $3,374 | -99.9% | 456,617 | +33.1% | 0.01% | 0.0% |
| Q3 2022 | $3,389,000 | +9.3% | 342,990 | +20.6% | 0.01% | +25.0% |
| Q2 2022 | $3,100,000 | +25.1% | 284,389 | +29.8% | 0.00% | +33.3% |
| Q1 2022 | $2,479,000 | -27.9% | 219,182 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,439,000 | -19.0% | 219,182 | -11.5% | 0.00% | -40.0% |
| Q3 2021 | $4,244,000 | – | 247,636 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |